SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-236721
Filing Date
2023-09-18
Accepted
2023-09-18 12:49:00
Documents
12
Period of Report
2023-09-18
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d511379d8k.htm   iXBRL 8-K 35622
  Complete submission text file 0001193125-23-236721.txt   156619

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA prtk-20230918.xsd EX-101.SCH 2856
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE prtk-20230918_lab.xml EX-101.LAB 17235
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prtk-20230918_pre.xml EX-101.PRE 10816
6 EXTRACTED XBRL INSTANCE DOCUMENT d511379d8k_htm.xml XML 3226
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Filer) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36066 | Film No.: 231260650
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences